
the podcast on
Pharmac is seeking clinical advice on whether weight loss medication should be funded in New Zealand.
One in three people over the age of 15 are classified as obese and one in eight children aged between two and 14.
Pharmac received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.
Auckland University Professor of Molecular Medicine Peter Shepherd told Andrew Dickens despite it being a short-term fix, it's like any other medicine.
He says it's the same as heart disease or blood pressure medication - as soon as you go off them, they lose their effect as well.
Take your Radio, Podcasts and Music with you
Get the iHeart App
Get more of the radio, music and podcasts you love with the FREE iHeart app. Scan the QR code to download now.
Download from the app stores
Stream unlimited music, thousands of radio stations and podcasts all in one app. iHeart is easy to use and all FREE
